Categories of Ageing Biomarkers
Key Takeaways
- Ageing biomarkers can be grouped into molecular, physiological, functional, and composite categories.
- These categories measure different biological levels and are not interchangeable.
- No single category captures all dimensions of ageing on its own.
- Composite measures can be useful, but they do not eliminate the need to understand what each component reflects.
Who This Is Useful For
This page is useful for readers trying to understand why different biomarker types are used in ageing research and why category matters before interpreting any specific metric. It is especially relevant for readers comparing molecular clocks, physiological tests, and functional performance measures.
Why Categories Matter
Biomarker categories are not just labels. They reflect different levels of biology, different measurement timescales, and different practical uses. Molecular biomarkers often track cellular or biochemical states, physiological biomarkers reflect organ-level performance, and functional biomarkers measure real-world capability. Composite measures try to integrate across these layers, but they still depend on the strengths and weaknesses of their components. [1] [10] [11]
Biomarker Categories at a Glance
| Category | Typical Examples | What It Captures Best | Main Limitation |
|---|---|---|---|
| Molecular | DNA methylation patterns, transcriptomic profiles, circulating proteins | Cellular and biochemical signatures linked to ageing processes | May be difficult to interpret clinically at the individual level |
| Physiological | Blood pressure, lung function, kidney function, inflammatory or endocrine measures | Organ and system-level performance relevant to age-related decline | Often influenced by disease burden, environment, and short-term context |
| Functional | Grip strength, gait speed, balance, cognitive performance tasks | Real-world capability and reserve | Can be shaped by motivation, injury, training, or non-ageing factors |
| Composite | Integrated biological age estimate models and multi-domain scores | Broader risk stratification by combining several inputs | Can hide which systems are actually driving the score |
Molecular Biomarkers
Molecular markers include DNA methylation patterns, gene expression profiles, and circulating proteins that reflect cellular processes tied to ageing. Reviews of ageing biology frame these markers as readouts of epigenetic alteration, genomic maintenance, and multi-omics signatures of biological age. [1] [2]
Physiological Biomarkers
These indicators reflect organ function and systemic performance, such as blood pressure, lung capacity, kidney filtration, and cardiovascular fitness, often including inflammatory and endocrine markers linked to age-related disease risk. [3] [4] [5]
Functional Biomarkers
Functional markers measure real-world capability, including walking speed, grip strength, balance, and cognitive tasks. They often predict outcomes such as disability and mortality and anchor frailty phenotypes used in clinical gerontology. [6] [7] [8]
Composite Measures
Some approaches combine multiple biomarkers into a single score. These composites aim to better capture overall biological age than any single metric and are commonly used in intervention studies and population risk stratification. [9] [10]
Evidence Quality and Interpretation
Confidence is strong that ageing biomarkers can be grouped into useful broad categories such as molecular, physiological, and functional measures. These groupings are widely used in both reviews and research practice. [1] [10] [11]
Confidence is also strong that no single category fully captures ageing alone. Each type of biomarker reflects a different biological layer and different practical endpoints. [1] [3] [6]
Confidence is moderate that composite measures can outperform single markers for some purposes, especially in risk prediction and intervention studies, but they do not solve all interpretation problems. [9] [10]
Confidence is weaker for treating any one taxonomy as the only correct classification system, because biomarker categories can overlap and the field continues to evolve. [11]
What This Does Not Mean
- It does not mean molecular biomarkers are automatically more informative than functional ones.
- It does not mean functional biomarkers are less scientific because they are easy to observe.
- It does not mean composite measures provide a complete whole-body truth about ageing.
- It does not mean category boundaries are always perfectly clean in practice.
Practical Interpretation Examples
- If an epigenetic clock changes: that may indicate a molecular shift without proving matching improvement in daily function.
- If grip strength is low: that can still be highly informative even though it is not a molecular measurement.
- If a composite score improves: the summary number may hide which biological system actually changed.
Related Reading
Summary
Ageing biomarkers fall into molecular, physiological, and functional categories, with composite models integrating multiple layers of information to estimate biological age. The usefulness of any biomarker depends not only on what it measures, but also on which biological level it reflects and how the result is being interpreted. [10] [11]
References
- Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023). The hallmarks of aging as a conceptual framework for biomarkers. Biogerontology, 24(1), 1-27. https://pmc.ncbi.nlm.nih.gov/articles/PMC10824251/
- Horvath, S., & Raj, K. (2018). DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nature Reviews Genetics, 19(2), 101-113. https://www.nature.com/articles/nrg.2017.115
- Kennedy, B. K., Berger, S. L., Brunet, A., et al. (2014). Geroscience: linking aging to chronic disease. Cell, 159(4), 709-713. https://pmc.ncbi.nlm.nih.gov/articles/PMC4292892/
- Ferrucci, L., & Fabbri, E. (2018). Inflammation: a key to understanding age-related diseases. Journal of Internal Medicine, 283(6), 573-591. https://pmc.ncbi.nlm.nih.gov/articles/PMC6882952/
- Expert consensus statement. (2025). Biomarkers of ageing for use in intervention studies. The Journals of Gerontology: Series A. https://repository.monashhealth.org/monashhealthjspui/handle/1/53106
- Cesari, M., Kritchevsky, S. B., Penninx, B. W., et al. (2009). Prognostic value of usual gait speed in well-functioning older people. JAMA, 301(17), 1782-1790. https://pmc.ncbi.nlm.nih.gov/articles/PMC2676397/
- Rantanen, T., Guralnik, J. M., Foley, D., et al. (1999). Midlife hand grip strength as a predictor of old age disability. JAMA, 281(6), 558-560. https://jamanetwork.com/journals/jama/fullarticle/188699
- Fried, L. P., Tangen, C. M., Walston, J., et al. (2001). Frailty in older adults: evidence for a phenotype. The Journals of Gerontology: Series A, 56(3), M146-M157. https://academic.oup.com/biomedgerontology/article/56/3/M146/545770
- Levine, M. E., Lu, A. T., Quach, A., et al. (2018). An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY), 10(4), 573-591. https://pmc.ncbi.nlm.nih.gov/articles/PMC5940111/
- Wang, T., et al. (2023). Biomarkers of aging for the identification and evaluation of longevity interventions. Cell, 186(15), 3243-3262. https://pmc.ncbi.nlm.nih.gov/articles/PMC10308275/
- Kennedy, B. K., et al. (2023). Biomarkers of aging - a review. Biogerontology, 24(3), 327-350. https://pmc.ncbi.nlm.nih.gov/articles/PMC10115486/
This content is provided for educational purposes only and does not constitute medical advice.